Market

Type 2 diabetes is a major health concern in all countries around the world. The industrialized world is strongly impacted.

Type 2 diabetes prevalence is estimated to grow to more than 340 million people by 2025 worldwide.

Type 2 Diabetes Prevalence Evolution

Type2-Diabetes-Prevalence-Evolution-Map
Source: Decision Resources


Type 2 diabetes market is a strongly growing market, with clearly identified growth factors:

Changes in modern way of life led to dramatic increase in obesity, a well known risk factor for developing type 2 diabetes. Indeed, approximately 70% of diabetic patients are overweighed or obese. Type 2 diabetes also sees high prevalence in emerging countries that adopt western life style.

Moreover, awareness of type 2 diabetes is growing significantly among physicians and patients as a result of increasing attention regarding the obesity epidemic and metabolic syndrome (a clustering of comorbid complications of obesity that include type 2 diabetes, hypertension, and dyslipidemia). This growing awareness will boost diagnosis and drug-treatment rates throughout the forecast period

The annual direct healthcare costs of diabetes worldwide, for people between 20 and 79, are estimated to be at least $153 billion and may be as much as $286 billion. Healthcare costs are expected to grow between $213 billion and $396 billion in 2025. The proportion of the world's healthcare budget being spent, in 2025, on diabetes care will be between 7% and 13% within high prevalence countries.
The world market of type 2 diabetes represented 12.7 billion euros in 2007, splitted as follows:

  • ~75% of oral anti-diabetic drugs (A10B)

  • ~25% of insulins (A10A)

In 2007, the worldwide market of oral anti-diabetic amounts to 9.6 billion euros.

This market will grow up to a turnover of 15 billion euros in 2016.